製品の概要

  • 製品名Anti-Paxillin antibody [E228]
    Paxillin 一次抗体 製品一覧
  • 製品の詳細
    Rabbit monoclonal [E228] to Paxillin
  • アプリケーション適用あり: WB, ICC/IF, IHC-P, IPmore details
    適用なし: Flow Cyt
  • 種交差性
    交差種: Mouse, Rat, Human
  • 免疫原

    Synthetic peptide within Human Paxillin aa 1-100 (phospho Y31). The exact sequence is proprietary.
    Database link: P49023
    (Peptide available as ab179557)

  • ポジティブ・コントロール
    • WB: NIH 3T3 cell lysate. ICC/IF: HeLa cells. IHC-P: Human colon carcinoma.
  • 特記事項

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab32115 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB 1/10000. Predicted molecular weight: 64 kDa.
ICC/IF 1/250.
IHC-P 1/100 - 1/250.
IP 1/100.
  • 追加情報Is unsuitable for Flow Cyt.
  • ターゲット情報

    • 機能Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion).
    • 配列類似性Belongs to the paxillin family.
      Contains 4 LIM zinc-binding domains.
    • 翻訳後修飾Phosphorylated on tyrosine residues during integrin-mediated cell adhesion, embryonic development, fibroblast transformation and following stimulation of cells by mitogens.
    • 細胞内局在Cytoplasm > cytoskeleton. Cell junction > focal adhesion.
    • Information by UniProt
    • 参照データベース
    • 別名
      • FLJ16691 antibody
      • FLJ23042 antibody
      • Paired box protein Pax 1 antibody
      • PAX 1 antibody
      • PAX1 antibody
      • PAXI_HUMAN antibody
      • Paxillin alpha antibody
      • Paxillin antibody
      • PXN antibody
      • PXN protein antibody
      see all

    Anti-Paxillin antibody [E228] 画像

    • Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling Paxillin with ab32115 at 1/100 (1 μg/ml). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000, 2 μg/ml) was used as the secondary antibody. The cells were counterstained with ab195889, anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200, 2.5 μg/ml. Nuclei counterstained with DAPI (blue). 

      Confocal image showing membranous staining on HeLa cells.

    • All lanes : Anti-Paxillin antibody [E228] (ab32115) at 1/1000 dilution

      Lane 1 : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates
      Lane 2 : HEK-293 (human embryonic kidney) whole cell lysates

      Lysates/proteins at 15 µg per lane.

      Secondary
      Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution

      Predicted band size : 64 kDa
      Observed band size : 64 kDa


      Exposure time : 3 minutes

      Blocking and diluting buffer and concentration: 5% NFDM/TBST.

    • Immunofluorescence analysis of HeLa cells, staining Paxillin with ab32115.

      Cells on the right were treated with MGAT1 shRNA. Cells were fixed with 2% paraformaldehyde, permeabilized using 0.2% Triton-X-100 and blocked by 5% BSA for 1 hour. Cells were incubated with primary antibody (1/400) overnight at 4°C. A FITC-conjugated donkey anti-rabbit IgG (1/500) was used as the secondary antibody.

    • All lanes : Anti-Paxillin antibody [E228] (ab32115) at 1/10000 dilution

      Lane 1 : untreated NIH 3T3 cell lysate
      Lane 2 : PDGF treated NIH 3T3 cell lysate


      Predicted band size : 64 kDa
      Observed band size : 64 kDa
    • Direct ELISA antigen dose-response curve using ab32115 at 0-1000 ng/mL. Antigen concentration of 1000 ng/mL. An alkaline phosphatase-conjugated goat anti-rabbit IgG (H+L) (1/2500) was used as the secondary antibody.

    • Dot blot analysis of Paxillin (pY31) peptide (Lane 1) and Paxillin non-phospho peptide (Lane 2) labelling Paxillin with ab32115 at a dilution of 1/1000. ab97051 (Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/100000.

      Blocking and dilution buffer: 5% NFDM/TBST.

      Exposure time: 3 minutes.

    • Immunohistochemical analysis of Paxillin expression in paraffin-embedded human colon carcinoma using 1/100 ab32115.

    Anti-Paxillin antibody [E228] (ab32115) 使用論文

    This product has been referenced in:
    • Sausgruber N  et al. Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases. Oncogene N/A:N/A (2014). WB . Read more (PubMed: 24931162) »
    • Beheshti Zavareh R  et al. Suppression of cancer progression by MGAT1 shRNA knockdown. PLoS One 7:e43721 (2012). ICC/IF ; Human . Read more (PubMed: 22957033) »

    See all 4 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab32115.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"